[A simple solid phase radioimmunoassay for plasma renin activity (author's transl)]

Area of Science:

• Biochemistry
• Endocrinology
• Assay Development

Context:

• Plasma renin activity (PRA) is a critical biomarker in cardiovascular and renal disease diagnostics.
• Accurate and efficient measurement of PRA is essential for clinical decision-making.
• Existing methods for PRA determination can be complex and time-consuming.

Purpose:

• To develop a simplified, single-tube solid-phase radioimmunoassay (RIA) for measuring plasma renin activity (PRA).
• To optimize enzymatic reaction conditions and angiotensin-I (A-I) determination for enhanced accuracy and efficiency.
• To validate the assay's performance characteristics, including recovery, precision, and correlation with established methods.

Summary:

• A novel solid-phase RIA was developed for PRA measurement, integrating enzymatic reaction and A-I determination in one tube.
• The assay utilizes phenylmethylsulfonyl fluoride (PMSF) and ethylenediamine tetraaceticacid (EDTA) to inhibit angiotensinase and converting enzymes, with Pepstatin A blocking renin activity.
• Optimized conditions (pH 6.0, 37°C incubation) yielded approximately double the PRA compared to pH 7.4, with high A-I recovery (102-105%) and excellent intra-assay (2.5-10.3%) and inter-assay (7.0-13.7%) precision.
• The developed RIA demonstrated a strong correlation (r=0.996) with an existing solid-phase RIA kit.
• Established normal PRA values for supine (1.03 ± 0.78 ng/mg/hr) and upright (1.33 ± 1.15 ng/ml/hr) positions were determined.

Impact:

• Provides a simpler, more reproducible method for PRA measurement, facilitating clinical application.
• Enhances the efficiency of diagnostic testing for conditions related to the renin-angiotensin-aldosterone system.
• Contributes to improved patient management through accurate and accessible PRA quantification.